MINI LONG - BAVARIAN NORDIC Share Price

Certificat

MINI L BAVARIAN

DK0062379400

Market Closed - Nasdaq Copenhagen
- ^DKK	-.--%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BAVARIAN NORDIC A/S

Latest news about BAVARIAN NORDIC A/S

Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024	05-08
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations	05-08	GL
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024	05-08	PU
Bavarian Nordic Announces Interim Results for the First Three Months of 2024	05-08	GL

More news

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	BAVARIAN NORDIC A/S
Issuer	Nordea
	MINI L BAVARIAN
ISIN	DK0062379400
Date issued	10/10/2023
Strike	96.29 kr
Maturity	Unlimited
Parity	1 : 1
Emission price	- kr
Emission volume	N/A
Settlement	cash
Currency	DKK

Technical Indicators

Spread	1.2 kr
Spread %	1.52%

Company Profile

Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases. Net sales by revenue source are divided between sales of products (97.8%) and services (2.2%). Net sales are distributed geographically as follows: the United States (36.5%), Canada (22%), France (10.5%), Germany (10.1%), Spain (6.1%), Australia (4.8%), Switzerland ( 1.5%), Sweden (1%), Chile (0.9%), Taiwan (0.8%), the United Kingdom (0.6%), Hong Kong (0.2%), Saudi Arabia (0.1%), and others (4.9%).

Sector

More about the company